Results 11 to 20 of about 256,850 (180)

Lanthanum Carbonate: Safety Data After 10 Years [PDF]

Nephrology, 2016
Despite 10years of post-marketing safety monitoring of the phosphatebinder lanthanum carbonate, concerns about aluminium-like accumulationand toxicity persist.
Rosamund J Wilson, Alastair J Hutchison
exaly   +4 more sources

Lanthanum carbonate oral powder: satisfaction, preference and adherence in French and Spanish patients with end-stage renal disease

Drugs in Context, 2016
Background: Phosphate binders, such as lanthanum carbonate, control elevated serum-phosphate levels in patients with end-stage renal disease (ESRD). Lanthanum carbonate is available in oral powder and tablet form.
Michael Keith, Patricia de Sequera, Francois Clair, Riccardo Pedersini   +3 more
doaj   +2 more sources

Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study [PDF]

BMC Nephrology, 2011
Background Lanthanum carbonate (FOSRENOL®) is an effective, well-tolerated phosphate binder. The ability of lanthanum to reduce serum phosphorus levels to ≤5.5 mg/dL in patients with end-stage renal disease (ESRD) was assessed in a clinical practice ...
Matalon Albert, Michelis Michael F, Vemuri Nirupama   +2 more
doaj   +3 more sources

Preparation and Characterization of Lanthanum Carbonate Octahydrate for the Treatment of Hyperphosphatemia [PDF]

Journal of Spectroscopy, 2013
We proposed a new approach to prepare lanthanum carbonate via reactions between lanthanum chloride and NaHCO3. In the reaction, small amount of NaHCO3 solution was firstly added to the acidic lanthanum chloride solution to generate lanthanum carbonate ...
Anqi He, Fengshan Zhou, Fang Ye, Ying Zhang, Xiren He, Xin Zhang, Ran Guo, Xing Zhao, Yan Sun, Ming Huang, Qin Li, Zhanlan Yang, Yizhuang Xu, Jinguang Wu   +13 more
doaj   +2 more sources

The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients

International Journal of Nephrology and Renovascular Disease, 2012
Takashi Shigematsu, Yuri Nakashima, Masaki Ohya, Koichi Tatsuta, Daisuke Koreeda, Wataru Yoshimoto, Shintaro Yamanaka, Toshifumi Sakaguchi, Yoshiyuki Hanba, Toru Mima, Shigeo NegiDivision of Nephrology, Department of Internal Medicine, Wakayama Medical ...
Shigematsu T, Nakashima Y, Ohya M, Tatsuta K, Koreeda D, Yoshimoto W, Yamanaka S, Sakaguchi T, Hanba Y, Mima T, Negi S   +10 more
doaj   +1 more source

All that glitters is not gold: A case of lanthanum carbonate aspiration [PDF]

SAGE Open Medical Case Reports, 2017
Introduction: Foreign body aspiration is a significant cause of morbidity and mortality in elderly hospitalized patients. These are typically small items that patients have access to, including small coins.
Suchitra Paranji, Neethi Paranji, Adam S Weltz   +2 more
doaj   +2 more sources

Gastric Lanthanum Deposition in Advanced CKD: An Underrecognized Diagnostic Pitfall in Refractory Anemia and Mucosal Injury [PDF]

International Journal of Nephrology
Lanthanum carbonate is a noncalcium phosphate binder used in advanced chronic kidney disease (CKD), especially in dialysis populations. Gastroduodenal lanthanum deposition is now a recognized histopathologic finding, but its clinical importance is ...
Yoshitaka Furuto, Daiki Yoshino, Iori Ejima, Sayako Ikeda, Akio Namikawa, Dai Sato, Yuko Shibuya   +6 more
doaj   +2 more sources

Effects of lanthanum carbonate versus calcium carbonate on vascular stiffness and bone mineral metabolism in hemodialysis patients with type 2 diabetes mellitus: a randomized controlled trial

International Journal of Nephrology and Renovascular Disease, 2015
Kentaro Wada,1 Yuko Wada,2 Haruhito Adam Uchida,3 Shuichi Tsuruoka4 1Division of Nephrology and Dialysis, Department of Internal Medicine, Nippon Kokan Fukuyama Hospital, Hiroshima, 2Department of Internal Medicine, Central Hospital, Hiroshima ...
Wada K, Wada Y, Uchida HA, Tsuruoka S
doaj   +1 more source

Therapeutic efficacy of lanthanum carbonate combined with meglumine cyclophosphate on patients with uremia cardiomyopathy

Linchuang shenzangbing zazhi, 2015
Objective To study the relationship of heart rate turbulence(HRT) in patients with uremia cardiomyopathy and investigate the curative effect and security of lanthanum carbonate combined with meglumine cyclophosphate(MAC) in patients with uremia ...
CHEN Xin, SUN Jian-ping, ZHOU Li-na, ZHOU Xiao-hua   +3 more
doaj   +1 more source

Lanthanum Deposition From Oral Lanthanum Carbonate in the Upper Gastrointestinal Tract [PDF]

Histopathology, 2017
Joseph Misdraji, Eric U. Yee, Gregory Y Lauwers   +2 more
exaly   +2 more sources